From American Chemical Society
ACS ProSpectives conferences planned on crystalline polymorphism in February and catalysis in March
The American Chemical Society, the world's largest scientific society, will hold ACS ProSpectives conferences on crystalline polymorphism in February and catalysis in March. Polymorphism in Crystals: Fundamentals, Prediction and Industrial Practice will be held Feb. 23-26 at the Saddle Brook Resort, Tampa, Fla., and Catalysis in Modern Organic Synthesis will be held March 2-5 at the Cambridge Marriott in Cambridge, Mass.
ACS ProSpectives is a series of small conferences for senior-level industry scientists. Each conference examines a field's important topics through presentations by its foremost researchers.Space is limited for both conferences.
Polymorphism in crystals conference
The state-of-the-art in the often-misunderstood field of crystalline polymorphism will be presented by leading experts in polymorph characterization and prediction, with an emphasis on industrial applications and practice. Among the topics at this meeting are crystallization fundamentals and strategies, polymorph prediction and modeling, polymorph characterization and screening and patenting polymorphs.
The conference also will explore new discoveries that are changing views about polymorphism.
Chairs for the conference: Robin D. Rogers, The University of Alabama; Allan Myerson, Illinois Institute of Technology; Susan Reutzel-Edens, Eli Lilly; and Roger J. Davey, UMIST (United Kingdom).
The conference will explore catalytic methodologies for organic synthesis, with a special emphasis on technologies with applications in pharmaceutical science. It will include discussion about which new synthetic methodologies will have the greatest impact on drug discovery and production.
Among the subjects to be addressed are asymmetric catalysis, catalysis in total synthesis, organocatalysis and C-C and C-X formation.
Conference chairs are Stephen Buchwald and Gregory Fu, both of MIT; and Eric Jacobsen, Harvard University.
This year's ACS ProSpectives conferences will concentrate on several areas of rapidly changing interdisciplinary research. Attendance at the conferences is limited to 200 or fewer to facilitate easy interaction among the speakers and those attending. From 20-25 leading experts in each field participate in a given conference.
"ACS ProSpectives conferences are unique in that they are designed in format and content solely to meet the needs of scientists employed in industry," according to John Katz, ACS ProSpectives program director. "We offer leading edge information presented by the world's foremost researchers, but keep our conferences small to optimize informal interaction among participants."
The conferences are in addition to the Society's two national meetings and its eight to ten regional meetings held every year. Following are the topics, conference chairs, dates and locations for the remaining confirmed 2003 ACS ProSpectives Conferences that follow those in February and March:
ADMET in the 21st Century: A Comprehensive Review of Technology and Strategic Applications
Rod Cole, Millennium Pharmaceuticals; Tim Olah, Bristol Myers Squibb
May 4-6, 2003
Combinatorial Chemistry: New Methods, New Discoveries
Anthony Czarnik, editor, Journal of Combinatorial Chemistry; Michael Organ, York
University, Canada; A. Ganesan, University of Southampton, UK
Lansdowne Conference Center
September 21-24, 2003
Integrating Proteomics into System Biology
Ruth Van Bogelen, Pfizer; Eric Neumann, Beyond Genomics
Lansdowne Conference Center
Nov. 9-12, 2003
Further details about the conferences, including instructions on how to register and arrange lodging, are available on www.acsprospectives.org. This site will be updated regularly with the latest information about upcoming ACS ProSpectives conferences.
(EDITOR's NOTE — News media wishing to attend the conferences should contact Michael Bernstein at 202-872-6042 or at email@example.com).